Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 12 min ago
PreprintAll rights reservedbioRxiv

Megakaryocytic proteomic signatures define myeloproliferative neoplasms

  • I. Raman
  • C. Bennett1
  • S.-R. Pasricha
  • R. Ataide
  • A. Pettikiriarachchi
  • J. Yousef
  • L. F. Gianni
  • C. K. Yannakou
  • S. J. Emery-Corbin
  • E. Tsui
  • Y. Zhu
  • P. Rajasekhar
3 more authors
  • A. Motyer
  • S. Juneja
  • S. Spall
  1. 1Walter and Eliza Hall Institute of Medical Research
Read full textPDFDOICite

Related

  1. The JAK2 V617F revolution in myeloproliferative neoplasms.
    Ayalew Tefferi
    HaematologicaPeer-reviewedCC BY-NCFull textHuman geneticsEurope PMCPMC
  2. FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms
    Diyaer Abuduaini, Diernu Simayi, Mihelayi Maimaiti +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach
    Raajit K. Rampal, Richard Winneker, Andrew Kuykendall +16
    LeukemiaPeer-reviewedCC BY 4.0Full textHuman geneticsPMC
  4. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
    Valérie Bardet, Wagner-Ballon O, Guy J +12
    HaematologicaPeer-reviewedLicence not statedFull text43 citedGeneral biologyGeneral medicineHAL
  5. PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications
    Avik Dutta, Lilian Varricchio, Ronald Hoffman +1
    LeukemiaPeer-reviewedCC BY 4.0Full textHuman geneticsPMC

Cite

BibTeXRIS
BibTeX
@misc{raman2026megakaryocytic,
  title = {{Megakaryocytic proteomic signatures define myeloproliferative neoplasms}},
  author = {I. Raman and C. Bennett and S.-R. Pasricha and R. Ataide and A. Pettikiriarachchi and J. Yousef and L. F. Gianni and C. K. Yannakou and S. J. Emery-Corbin and E. Tsui and Y. Zhu and P. Rajasekhar and A. Motyer and S. Juneja and S. Spall},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.30.762990},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.30.762990v1},
}
RIS
TY  - UNPB
TI  - Megakaryocytic proteomic signatures define myeloproliferative neoplasms
AU  - I. Raman
AU  - C. Bennett
AU  - S.-R. Pasricha
AU  - R. Ataide
AU  - A. Pettikiriarachchi
AU  - J. Yousef
AU  - L. F. Gianni
AU  - C. K. Yannakou
AU  - S. J. Emery-Corbin
AU  - E. Tsui
AU  - Y. Zhu
AU  - P. Rajasekhar
AU  - A. Motyer
AU  - S. Juneja
AU  - S. Spall
PY  - 2026
DA  - 2026/10/30
PB  - bioRxiv
DO  - 10.64898/2026.10.30.762990
UR  - https://www.biorxiv.org/content/10.64898/2026.10.30.762990v1
ER  -